Clinical Trial

Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.

Name: Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects. — clinical trial record (NCT07322991)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this stud is to evaluate the drug-drug interaction between IY001 and IY002 in adult males.

Trial Details

NCT Number	NCT07322991
Lead Sponsor	Il-Yang Pharm. Co., Ltd.
Conditions	Healthy Adult Male
Enrollment	43 participants
Start Date	2025-10-14
Primary Completion	2025-12-01 (estimated)
Study Completion	2025-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-07